[Enlivex, Longevity Pharmaceutical Company, Secures $21 Million in Debt Financing] According to The Block, longevity pharmaceutical company and RAIN token treasury Enlivex announced it has secured $21 million in debt financing from New York institutional fund The Lind Partners. The company stated it will continue to implement its predictive market token treasury strategy, adding approximately 3 billion RAIN tokens to support its operational plans. Enlivex, a Nasdaq-listed company, is developing therapies for joint diseases such as osteoarthritis while also holding a significant RAIN position as part of its digital asset treasury. RAIN is the decentralized predictive market protocol token deployed on the Arbitrum network. Its protocol determines outcomes using AI and employs a buyback-and-burn mechanism. Enlivex's stock is currently trading at approximately $1.05, down about 5% on the day.